Drug intelligence / Profile preview

technetium Tc 99m fucoidan

Development stage
Phase 1
Lead developer
Inserm
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

Technetium Tc 99m fucoidan is an investigational radiopharmaceutical tracer designed for the molecular imaging of P-selectin expression using Single Photon Emission Computed Tomography (SPECT). The agent consists of the radioisotope technetium-99m complexed with fucoidan, a sulfated polysaccharide extracted from brown seaweed. Fucoidan acts as a high-affinity ligand for P-selectin (CD62P), a cell adhesion molecule that is rapidly translocated to the surface of activated platelets and endothelial cells during inflammatory and thrombotic events. By targeting P-selectin, technetium Tc 99m fucoidan allows for the non-invasive detection of active thrombi, vulnerable atherosclerotic plaques, and ischemia-reperfusion injury. Development has primarily been driven by academic research institutions in France, focusing on cardiovascular indications such as venous thromboembolism and abdominal aortic aneurysm.

Other names
technetium-99m labeled fucoidantechnetium99m labeled fucoidantechnetium 99m labeled fucoidan99mTc-labelled fucoidantechnetium Tc 99m fucose sulfate
02

Targets

SELP (P-selectin)

Beyond the preview

Go deeper on technetium Tc 99m fucoidan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on technetium Tc 99m fucoidan.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call